AL
IBDL

Aspiriant LLC’s iShares iBonds Dec 2020 Term Corporate ETF IBDL Stock Holding History

Aspiriant LLC’s Portfolio IBDL Stock Details IBDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Hold
0
– – – 51
2019
Q2 		– Hold
0
– – – 58
2019
Q1 		– Sell
-120,000
Closed -$3.02M – 58
2018
Q4 		$3M Hold
120,000
– – 0.23% 63
2018
Q3 		$3M Buy
+120,000
New +$3M 0.26% 58

Other funds holding IBDL

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
RVPG
Relative Value Partners Group $772M AUM 15.6% 1-Year Est. Return
CIM
Corda Investment Management Houston, Texas $1.45B AUM 22.99% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

Aspiriant LLC's IBDL Position: Q3 2019 in Review

Aspiriant LLC held its iShares iBonds Dec 2020 Term Corporate ETF (IBDL) position steady in Q3 2019 at 0 shares worth $3.13M. The position accounts for 0.28% of the portfolio, ranked #51.

Aspiriant LLC first reported a position in IBDL in Q3 2018 and has held it in 2 quarters since. The position peaked at $3M in Q3 2018. 149 funds tracked by Wall St. Rank hold IBDL as of Q3 2019.

  • Aspiriant LLC held 0 shares of iShares iBonds Dec 2020 Term Corporate ETF worth $3.13M as of Q3 2019.
  • Aspiriant LLC left its iShares iBonds Dec 2020 Term Corporate ETF share count unchanged in Q3 2019.
  • iShares iBonds Dec 2020 Term Corporate ETF made up 0.28% of Aspiriant LLC's portfolio in Q3 2019, its #51 holding.
  • Aspiriant LLC first reported a position in iShares iBonds Dec 2020 Term Corporate ETF in Q3 2018 and has held it in 2 quarters since.
  • Aspiriant LLC's iShares iBonds Dec 2020 Term Corporate ETF position peaked at $3M in Q3 2018.
  • 149 funds tracked by Wall St. Rank held iShares iBonds Dec 2020 Term Corporate ETF as of Q3 2019.

Based on Aspiriant LLC's 13F filing for Q3 2019, filed 4 Nov 2019.